Ruma Maji

1.1k total citations
18 papers, 767 citations indexed

About

Ruma Maji is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Ruma Maji has authored 18 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 6 papers in Molecular Biology and 6 papers in Biomaterials. Recurrent topics in Ruma Maji's work include Nanoparticle-Based Drug Delivery (6 papers), Advancements in Transdermal Drug Delivery (4 papers) and Drug Solubulity and Delivery Systems (4 papers). Ruma Maji is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Advancements in Transdermal Drug Delivery (4 papers) and Drug Solubulity and Delivery Systems (4 papers). Ruma Maji collaborates with scholars based in India, United States and South Africa. Ruma Maji's co-authors include Amit Kumar Nayak, B. Krishna Das, Biswajit Mukherjee, Bhabani Sankar Satapathy, Subhasish Mondal, Thirumala Govender, Calvin A. Omolo, Kalyan Kumar Sen, Chunderika Mocktar and Nikhil Agrawal and has published in prestigious journals such as International Journal of Pharmaceutics, RSC Advances and International Journal of Biological Macromolecules.

In The Last Decade

Ruma Maji

18 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruma Maji India 15 384 205 168 121 103 18 767
Dalia Attia Egypt 16 344 0.9× 172 0.8× 151 0.9× 184 1.5× 83 0.8× 32 949
Suzana Gonçalves Carvalho Brazil 15 253 0.7× 269 1.3× 147 0.9× 140 1.2× 116 1.1× 35 764
Victor Hugo Sousa Araújo Brazil 18 310 0.8× 231 1.1× 259 1.5× 120 1.0× 136 1.3× 39 945
Mohsen A. Bayomi Saudi Arabia 16 442 1.2× 197 1.0× 181 1.1× 95 0.8× 75 0.7× 31 804
Alaa Eldeen B. Yassin Saudi Arabia 19 618 1.6× 276 1.3× 300 1.8× 131 1.1× 132 1.3× 46 1.1k
Kenneth C. Ofokansi Nigeria 16 369 1.0× 147 0.7× 152 0.9× 115 1.0× 59 0.6× 34 725
Ana S. Macedo Portugal 15 410 1.1× 145 0.7× 271 1.6× 241 2.0× 71 0.7× 28 930
Elizabeth ̈Piñón-Segundo Mexico 14 312 0.8× 250 1.2× 114 0.7× 92 0.8× 148 1.4× 23 773
Luíse Lopes Chaves Brazil 17 407 1.1× 202 1.0× 201 1.2× 95 0.8× 77 0.7× 42 861
Mireia Mallandrich Spain 17 430 1.1× 129 0.6× 119 0.7× 101 0.8× 97 0.9× 60 848

Countries citing papers authored by Ruma Maji

Since Specialization
Citations

This map shows the geographic impact of Ruma Maji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruma Maji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruma Maji more than expected).

Fields of papers citing papers by Ruma Maji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruma Maji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruma Maji. The network helps show where Ruma Maji may publish in the future.

Co-authorship network of co-authors of Ruma Maji

This figure shows the co-authorship network connecting the top 25 collaborators of Ruma Maji. A scholar is included among the top collaborators of Ruma Maji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruma Maji. Ruma Maji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sayyad, Nisar, Ruma Maji, Calvin A. Omolo, et al.. (2021). Development of niosomes for encapsulating captopril-quercetin prodrug to combat hypertension. International Journal of Pharmaceutics. 609. 121191–121191. 14 indexed citations
2.
Maji, Ruma, Calvin A. Omolo, Sanil D. Singh, et al.. (2021). A transferosome-loaded bigel for enhanced transdermal delivery and antibacterial activity of vancomycin hydrochloride. International Journal of Pharmaceutics. 607. 120990–120990. 49 indexed citations
3.
Hazzah, Heba A., Calvin A. Omolo, Nikhil Agrawal, et al.. (2020). Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). Amino Acids. 52(10). 1439–1457. 34 indexed citations
4.
Maji, Ruma, Calvin A. Omolo, Nikhil Agrawal, et al.. (2019). pH-Responsive Lipid–Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens. Molecular Pharmaceutics. 16(11). 4594–4609. 59 indexed citations
5.
Das, B. Krishna, et al.. (2017). Transferosomal gel for transdermal delivery of risperidone: Formulation optimization and ex vivo permeation. Journal of Drug Delivery Science and Technology. 38. 59–71. 65 indexed citations
6.
Satapathy, Bhabani Sankar, et al.. (2016). Lipid nanocarrier-based transport of docetaxel across the blood brain barrier. RSC Advances. 6(88). 85261–85274. 29 indexed citations
7.
Mukherjee, Biswajit, et al.. (2016). Variation of Pharmacokinetic Profiles of Some Antidiabetic Drugs from Nanostructured Formulations Administered Through Pulmonary Route. Current Drug Metabolism. 17(3). 271–278. 3 indexed citations
8.
Mukherjee, Biswajit, et al.. (2015). Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer. Current Cancer Drug Targets. 16(4). 357–372. 22 indexed citations
9.
Mukherjee, Biswajit, et al.. (2015). Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology. Current Pharmaceutical Design. 21(36). 5172–5186. 3 indexed citations
10.
Mukherjee, Biswajit, et al.. (2014). Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles. Current Pharmaceutical Biotechnology. 14(15). 1250–1263. 21 indexed citations
11.
Mukherjee, Biswajit, et al.. (2014). Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. International Journal of Nanomedicine. 9. 3107–3107. 98 indexed citations
12.
Mukherjee, Biswajit, et al.. (2013). Toxicological Concerns of Engineered Nanosize Drug Delivery Systems. American Journal of Therapeutics. 23(1). e139–e150. 19 indexed citations
13.
Mukherjee, Biswajit, Paramita Paul, Ajeet Kumar, et al.. (2012). Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study. International Journal of Nanomedicine. 7. 6049–6049. 30 indexed citations
14.
Maji, Ruma, Somasree Ray, B. Krishna Das, & Amit Kumar Nayak. (2012). Ethyl Cellulose Microparticles Containing Metformin HCl by Emulsification-Solvent Evaporation Technique: Effect of Formulation Variables. 2012. 1–7. 35 indexed citations
15.
Nayak, Amit Kumar, B. Krishna Das, & Ruma Maji. (2012). Calcium alginate/gum Arabic beads containing glibenclamide: Development and in vitro characterization. International Journal of Biological Macromolecules. 51(5). 1070–1078. 126 indexed citations
16.
Nayak, Amit Kumar, B. Krishna Das, & Ruma Maji. (2011). Gastroretentive hydrodynamically balanced systems of ofloxacin: In vitro evaluation. Saudi Pharmaceutical Journal. 21(1). 113–117. 23 indexed citations
17.
Nayak, Amit Kumar, et al.. (2010). Gastroretentive drug delivery systems: a review. 134 indexed citations
18.
Maji, Ruma, et al.. (2007). Improvement of polymer blend properties by changing sequence of mixing. Journal of Applied Polymer Science. 104(4). 2735–2742. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026